- Report
- February 2021
- 360 Pages
United States
From €2303EUR$2,400USD£1,991GBP
Aptivus is a brand of antiretroviral drug used to treat HIV infection and AIDS. It is a protease inhibitor, which works by blocking the action of the HIV protease enzyme, preventing the virus from replicating. Aptivus is used in combination with other antiretroviral drugs to treat HIV infection and AIDS. It is also used to reduce the risk of HIV transmission from mother to child during pregnancy and childbirth.
The Aptivus market is a subset of the larger infectious diseases drugs market. It is composed of pharmaceutical companies that produce and market antiretroviral drugs, such as Aptivus, for the treatment of HIV and AIDS. These companies are involved in the research, development, manufacturing, and marketing of antiretroviral drugs.
Some companies in the Aptivus market include Boehringer Ingelheim, Gilead Sciences, Merck & Co., and ViiV Healthcare. Show Less Read more